Find and Pitch Jounalists, Get Your Story Covered

Tags: leadership pharma Research & Development research-development biotech

	Profile	Recent Articles on Subject
1	Mike Hennessy Jr, President and CEO Pharmacy Times Pro middleweight boxer. UK/Ireland. BoxingSports	Turning the Page - 4 days ago
2	Elaine Chen STAT News Reporter at STATnews. Formerly at Business Insider. Chicago, Illinois journalism	A key decision on compounding is expected this week - 4 days ago
3	Meagan Parrish Pharma Voice Senior editor @industrydive. Pharma world follower. Wisconsin, USA pharmaceuticalsjournalismparenting	3 closely watched drugs that failed in the clinic - 6 days ago The big rebrand: Why these 4 biopharmas changed their name this year - 18 days ago 2024 PharmaVoice 100s: Rare Disease Warriors - about 2 months ago 2024 PharmaVoice 100s: Trailblazers - 2 months ago Who’s winning in biotech’s tight market? - 3 months ago What 3 layoff stories reveal about pharma’s troubles - 4 months ago What pharma has learned from AI - 5 months ago Pharma’s R&D gamble: picking pipeline winners in a risky field - 7 months ago Where competition is heating up in pharma - 7 months ago 3 big recent trial flops - 8 months ago The biggest questions hanging over pharma in 2024 - 11 months ago Pharma execs sound off on trends and policies they’re tracking in 2024 - 11 months ago PharmaVoice’s Crystal Ball: What’s next in drug innovation and clinical trials - 12 months ago 10 of our most read articles in 2023 - 12 months ago 3 standout digital innovations in pharma this year - about 1 year ago PharmaVoice 100s: Entrepreneurs - about 1 year ago PharmaVoice 100s: Clinical trial gurus - about 1 year ago 3 recent FDA adcomm rejections — and why they matter - about 1 year ago
4	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Up and down the ladder: The latest comings and goings - 9 days ago STAT+: Up and down the ladder: The latest comings and goings - 16 days ago STAT+: Pharmalittle: We’re reading about GSK leaving BIO, an AbbVie schizophrenia drug failing, and more - about 1 month ago STAT+: Up and down the ladder: The latest comings and goings - about 1 month ago STAT+: Up and down the ladder: The latest comings and goings - about 2 months ago STAT+: Pharmalittle: We’re reading about pharma risks in China, mitigating shortages, and more - about 2 months ago STAT+: Up and down the ladder: The latest comings and goings - about 2 months ago STAT+: Up and down the ladder: The latest comings and goings - 2 months ago STAT+: Up and down the ladder: The latest comings and goings - 3 months ago STAT+: Pharmalittle: We’re reading about Moderna R&D cuts, Lilly plant investments and more - 3 months ago STAT+: Up and down the ladder: The latest comings and goings - 4 months ago STAT+: Up and down the ladder: The latest comings and goings - 8 months ago STAT+: Up and down the ladder: The latest comings and goings - 8 months ago STAT+: Pharmalittle: We’re reading about Biocon eyeing weight loss drugs, Sanofi layoffs, and more - 9 months ago STAT+: Pharmalittle: We’re reading about Amgen suing Colorado over drug price caps, abortion pills, and more - 9 months ago STAT+: Up and down the ladder: The latest comings and goings - 9 months ago STAT+: Pharmalittle: We’re reading about Lilly selling drugs directly, UCB leaving BIO, and more news - 12 months ago STAT+: Pharmalittle: FDA approvals rebound, abortion pill orders rise, and more news - 12 months ago STAT+: Pharmalittle: Novo Nordisk sees “significantly” more Wegovy in the U.S. next year; U.S. pharma layoffs skyrocket - about 1 year ago
5	John Wilkerson STAT News STAT Washington correspondent. Healthcare Journalism	STAT+: Pharma giant GSK is quitting BIO in latest setback for the lobbying group - about 1 month ago
6	Lizzy Lawrence STAT News Medical devices reporter at STATnews. Loves news tips. medical reportingnews	STAT+: Pharma giant GSK is quitting BIO in latest setback for the lobbying group - about 1 month ago
7	Sarah Owermohle STAT News Health reporter @STATNews. Covers Biden's agenda. Washington, District of Columbia health policyjournalism	STAT+: Pharma giant GSK is quitting BIO in latest setback for the lobbying group - about 1 month ago
8	PT Staff Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	October 2024 Product News - 2 months ago June 2024 Products Column - 6 months ago
9	N. Adam Brown MD MedPage Today Healthcare Strategist/Communicator. Washington, D.C. Healthcarestrategycommunication	Direct-to-Consumer Drugs: Big Pharma's Digital Health Play - 3 months ago
10	Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia pain relieftechnologyinnovation	3 FDA approval dates to watch in the year’s final push - 3 months ago Read to lead: 6 books pharma execs swear by - 5 months ago 4 offbeat biotechs making a splash in the life sciences - 8 months ago

Journalists covering BioPharma, Daily, Legal, Pharma